Linagliptin methyldimer

• UNSPSC Description:

  Linagliptin methyldimer is an impurity of Linagliptin. Linagliptin is a DPP-IV inhibitor, with IC50 of 1 nM[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/linagliptin-methyldimer.html

• Purity:

  96.12

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  O=C(N(C1=C(C2=O)N(C(N3C[C@@H](CCC3)N)=N1)CC#CC)C)N2CC4=NC(CC5(N=C(NC6=C5C=CC=C6)CN7C(N(C8=C(C7=O)N(C(N9C[C@@H](CCC9)N)=N8)CC#CC)C)=O)C)=C%10C=CC=CC%10=N4

• Molecular Weight:

  945.08

• References & Citations:

  [1]Pfrengle, et al. Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions as DPP-IV inhibitors. Patent. WO2013010964 A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  1418133-47-7